netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

EMERGING VISION SCIENTISTS EDUCATE, THANK CONGRESS FOR RESEARCH APPROPRIATIONS

On September 27, the National Alliance for Eye and Vision Research (NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill.  Twenty early-stage investigators participated.

The event occurred as Congress passed—and the President signed—H.R. 6157, the minibus Fiscal Year (FY) 2019 spending bill, which finalized Defense and Labor, Health and Human Services, and Education (LHHS) appropriations prior to the end of FY2018. The LHHS bill includes a $2 billion National Institutes of Health (NIH) increase and a $24.2 million National Eye Institute (NEI) increase.  The Defense bill provides a $5 million increase in the Peer Reviewed Vision Research Program (VRP), to a record funding level of $20 million.

EVS scientists and RPB

Emerging Vision Scientists and RPB visit the office of Senator Charles Schumer 

For the fourth year, RPB provided a grant to support the EVS events. RPB President Dr. Brian Hofland accompanied Drs. Giles-Hamilton Fletcher and Dr. Rachel Wozniak in New York delegation visits.  Dr. Hofland commented:  “It was wonderful that FY2019 NIH and NEI appropriations already were finalized, enabling participants to present their breakthrough research and describe plans to submit their first Investigator-Initiated (R01) grant within that positive context.  EVSs emphasized how their research has the potential both to improve quality of life and reduce healthcare costs. Congressional staff were especially receptive to this messaging about the value of the nation’s investment in vision research.” 

Class of 2018 Emerging Vision Scientists

The class of the Fourth Annual Emerging Vision Scientists Day

The investigators attended NAEVR’s annual International AMD Awareness Week Congressional Briefing, provided on-camera interviews about their research for a documentary video, and displayed posters of their research in an evening Congressional Reception. On September 28, under the auspices of NAEVR, they visited their Congressional delegation offices and thanked their representatives.

“I continue to be impressed with the passion, knowledge, and drive of these early-career investigators,” said Dr. Hofland.  “I am proud of RPB’s role in providing early grant support of the next generation of vision scientists as they proceed to seek federal funding.”

Both the educational and advocacy activities were built around one question—“How will the breakthrough research being conducted by these EVSs prevent, delay, and treat vision disorders--which will grow to an annual United States cost burden of $717 billion in inflation-adjusted dollars by 2050?”

 

 

Related News: Events, Feature Story, Top Story

RPB-SUPPORTED RESEARCHERS WILL BE INTEGRAL PART OF LATEST EFFORT WITHIN NEI’S AUDACIOUS GOALS INITIATIVE

Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.

Read More

 

RESEARCH TO PREVENT BLINDNESS AND LIONS CLUBS INTERNATIONAL FOUNDATION TO CONTINUE LOW VISION RESEARCH AWARD PARTNERSHIP

Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.

Read More

 

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Read More

 

IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS

RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.

Read More

 

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research

RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.

Read More

 

Groundbreaking Gene Therapy for Retinal Disease

The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.